1. Home
  2. ZNTL vs TTSH Comparison

ZNTL vs TTSH Comparison

Compare ZNTL & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZNTL
  • TTSH
  • Stock Information
  • Founded
  • ZNTL 2014
  • TTSH 1985
  • Country
  • ZNTL United States
  • TTSH United States
  • Employees
  • ZNTL N/A
  • TTSH N/A
  • Industry
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • TTSH Blank Checks
  • Sector
  • ZNTL Health Care
  • TTSH Finance
  • Exchange
  • ZNTL Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • ZNTL 300.4M
  • TTSH 319.7M
  • IPO Year
  • ZNTL 2020
  • TTSH N/A
  • Fundamental
  • Price
  • ZNTL $4.31
  • TTSH $6.95
  • Analyst Decision
  • ZNTL Buy
  • TTSH
  • Analyst Count
  • ZNTL 7
  • TTSH 0
  • Target Price
  • ZNTL $13.14
  • TTSH N/A
  • AVG Volume (30 Days)
  • ZNTL 1.3M
  • TTSH 125.6K
  • Earning Date
  • ZNTL 08-07-2024
  • TTSH 08-01-2024
  • Dividend Yield
  • ZNTL N/A
  • TTSH N/A
  • EPS Growth
  • ZNTL N/A
  • TTSH N/A
  • EPS
  • ZNTL N/A
  • TTSH 0.21
  • Revenue
  • ZNTL $40,560,000.00
  • TTSH $366,855,000.00
  • Revenue This Year
  • ZNTL N/A
  • TTSH $8.17
  • Revenue Next Year
  • ZNTL N/A
  • TTSH N/A
  • P/E Ratio
  • ZNTL N/A
  • TTSH $33.55
  • Revenue Growth
  • ZNTL N/A
  • TTSH N/A
  • 52 Week Low
  • ZNTL $3.27
  • TTSH $4.33
  • 52 Week High
  • ZNTL $29.03
  • TTSH $7.67
  • Technical
  • Relative Strength Index (RSI)
  • ZNTL 39.15
  • TTSH 50.02
  • Support Level
  • ZNTL $3.59
  • TTSH $6.91
  • Resistance Level
  • ZNTL $4.79
  • TTSH $7.16
  • Average True Range (ATR)
  • ZNTL 0.44
  • TTSH 0.22
  • MACD
  • ZNTL 0.29
  • TTSH -0.02
  • Stochastic Oscillator
  • ZNTL 68.42
  • TTSH 45.00

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers, and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: